GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
ANBARI, JILL MARINIS,BERTIN, JOHN J.,JEONG, JAE U.
申请号：
CA3052767
公开号：
CA3052767A1
申请日:
2018.02.23
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
Disclosed is a combination of a RIP1 kinase inhibitor compound and at least one other therapeutically active agent for use in the treatment of a RIP1 kinase mediated disease or disorder； particularly disclosed is a combination of a RIP1 kinase inhibitor compound and at least one other therapeutically active agent, wherein the at least one other therapeutically active agent is an immuno-modulator, for use in the treatment of cancer.
